Letter/Communication
COVID-19 Vaccine Uptake and Intentions Following US Food and Drug Administration Approval of the Pfizer-BioNTech COVID-19 Vaccine
JAMA internal medicine, Vol.182(6), pp.678-680
04/11/2022
DOI: 10.1001/jamainternmed.2022.0761
PMCID: PMC9002709
PMID: 35404416
Abstract
This survey study assesses vaccination intentions of unvaccinated US adults in response to full US Food and Drug Administration (FDA) approval of the BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine and any demographic characteristics associated with those intentions.
Details
- Title: Subtitle
- COVID-19 Vaccine Uptake and Intentions Following US Food and Drug Administration Approval of the Pfizer-BioNTech COVID-19 Vaccine
- Creators
- Aaron M Scherer - University of IowaAndrew M ParkerCourtney A Gidengil - Boston Children's HospitalAmber M Gedlinske - University of IowaNatoshia M Askelson - University of IowaChristine A Petersen - University of IowaMegan C Lindley - Centers for Disease Control and Prevention
- Resource Type
- Letter/Communication
- Publication Details
- JAMA internal medicine, Vol.182(6), pp.678-680
- DOI
- 10.1001/jamainternmed.2022.0761
- PMID
- 35404416
- PMCID
- PMC9002709
- NLM abbreviation
- JAMA Intern Med
- eISSN
- 2168-6114
- Grant note
- U01 IP001144 / NCIRD CDC HHS K01 AG065440 / NIA NIH HHS
- Language
- English
- Electronic publication date
- 04/11/2022
- Academic Unit
- Epidemiology; Injury Prevention Research Center; Public Policy Center (Archive); General Internal Medicine; Community and Behavioral Health; Internal Medicine
- Record Identifier
- 9984242657402771
Metrics
62 Record Views